D. Sakuma, H. Togo / Tetrahedron 61 (2005) 10138–10145
10143
and 125 MHz spectrometers. Chemical shifts are expressed
in ppm downfield from TMS in d units. In the 13C NMR
spectra, p, s, t, and q means primary, secondary, tertiary,
quaternary. Mass spectra were recorded on HX-110 and
JMS-AT II 15 spectrometers. IR spectra were measured
with an FT/IR-200 spectrometer. Silica Gel 60 was used for
column chromatography, and Wakogel B-5F was used for
preparative TLC. Zinc powder (no. 48005-30) was obtained
from Kanto Kagaku Co, and used directly without any pre-
treatment.
(100 MHz, CDCl3) dZ200.3 (q), 137.0 (q), 132.8 (t),
128.5 (t), 128.0 (t), 39.2 (s), 27.1 (p), 20.2 (p), 19.8 (s), 19.6
(t), 15.4 (q); MS (FAB): m/z 189; HRMS (FAB) found:
189.1268 m/z, calcd for C13H17O: MCHZ189.1279.
4.2.5. 2-(20,20-Dimethylcyclopropyl)-1-piperidinyletha-
none (2h). Colorless oil; IR (neat) 2940, 1640, 1440,
1
1250, 1220 cmK1; H NMR (400 MHz, CDCl3) dZ3.56
(2H, dt, JZ5.3, 5.1 Hz), 3.40 (2H, m), 2.44 (1H, dd, JZ
15.5, 6.3 Hz), 2.24 (1H, dd, JZ15.5, 7.5 Hz), 1.68–1.50
(6H, m), 1.08 (3H, s), 1.05 (3H, s), 0.90–0.79 (1H, dddd, JZ
8.6, 7.5, 6.3, 4.7 Hz), 0.52 (1H, dd, JZ8.6, 4.7 Hz), 0.04
(1H, t, JZ4.7 Hz); 13C NMR (100 MHz, CDCl3) dZ171.4
(q), 46.8 (s), 42.7 (s), 34.0 (s), 27.1 (p), 26.6 (s), 25.6 (s),
24.6 (s), 20.5 (t), 20.2 (p), 19.8 (s), 15.4 (q); MS (FAB): m/z
196; HRMS (FAB) found: 196.1718 m/z, calcd for
C12H22O14N: MCHZ196.1701.
4.2. General procedure for zinc-mediated cyclopro-
panation of electron-deficient 2-iodoethyl-substituted
olefins
Zinc powder (1.2 mmol) was added to a refluxing solution
of 2-iodoethyl olefin (0.4 mmol) in a mixture of t-BuOH
(2 mL) and water (1 mL) under an argon atmosphere. After
0.5–5 h at the same temperature, the mixture was filtered
through Celitew, then the solvent was removed, and the
residue was purified by preparative TLC or column
chromatography on silica gel.
4.2.6.
(2,2-Dimethylcyclopropyl)methanesulfonyl-
benzene (2i). Colorless oil; IR (neat) 2950, 1300, 1150,
750, 690 cmK1; 1H NMR (400 MHz, CDCl3) dZ7.93 (2H,
m), 7.66 (1H, tt, JZ7.4, 1.5 Hz), 7.57 (2H, m), 3.22 (1H, dd,
JZ14.5, 7.0 Hz), 3.05 (1H, dd, JZ14.5, 7.2 Hz), 0.98 (3H,
s), 0.91–0.83 (1H, dddd, JZ8.7, 7.2, 7.0, 5.0 Hz), 0.78 (3H,
s), 0.52 (1H, dd, JZ8.7, 5.0 Hz), 0.00 (1H, t, JZ5.0 Hz);
13C NMR (100 MHz, CDCl3) dZ139.1 (q), 133.5 (t), 129.0
(t), 128.4 (t), 57.5 (s), 26.4 (p), 19.9 (p), 19.2 (s), 17.6 (t),
16.1 (q); MS (FAB): m/z 225; HRMS (FAB) found:
225.0935 m/z, calcd for C12H17O2S: MCHZ225.0949.
4.2.1. Benzyl (2,2-dimethylcyclopropyl)acetate (2a).
1
Colorless oil; IR (neat) 2950, 1740, 750, 700 cmK1; H
NMR (400 MHz, CDCl3) dZ7.40–7.28 (5H, m), 5.14 (2H,
s), 2.37 (2H, d, JZ7.6 Hz), 1.05 (3H, s), 1.02 (3H, s), 0.94–
0.84 (1H, m), 0.51 (1H, dd, JZ8.5, 4.6 Hz), 0.03 (1H, t, JZ
4.6 Hz); 13C NMR (100 MHz, CDCl3) dZ173.6 (q), 136.2
(q), 128.5 (t), 128.1 (t), 66.1 (s), 35.0 (s), 27.0 (p), 20.0 (p),
19.9 (t), 19.5 (s), 15.4 (q); MS (FAB): m/z 218; HRMS (EI)
found: 218.1297 m/z, calcd for C14H18O2: MCZ218.1307.
4.2.7. 2,2-Dimethyl cyclopropanecarbaldehyde oxime
1
(2j). H NMR (400 MHz, CDCl3) syn form: dZ6.68 (1H,
d, JZ8.6 Hz), 2.14 (1H, td, JZ8.6, 5.1 Hz), 1.18 (3H, s),
1.17 (3H, s), 0.96 (1H, dd, JZ8.6, 5.1 Hz), 0.65 (1H, t, JZ
5.1 Hz); anti form: dZ7.22 (2H, d, JZ8.5 Hz), 1.44 (1H, td,
JZ8.5, 5.1 Hz), 1.14 (6H, s), 0.84 (1H, dd, JZ8.5, 5.1 Hz),
0.66 (1H, t, JZ5.1 Hz).
4.2.2. Benzyl 2-spiro[2.5]octylacetate (2e). Colorless oil;
IR (neat) 2930, 1740, 750, 700 cmK1; 1H NMR (400 MHz,
CDCl3) dZ7.40–7.27 (5H, m), 5.14 (2H, s), 2.45 (1H, dd,
JZ16.3, 7.2 Hz), 2.34 (1H, dd, JZ16.3, 7.6 Hz), 1.58–1.12
(10H, m), 0.94–0.85 (1H, dddd, JZ8.5, 7.6, 7.2, 4.7 Hz),
0.48 (1H, dd, JZ8.5, 4.7 Hz), 0.03 (1H, t, JZ4.7 Hz); 13C
NMR (100 MHz, CDCl3) dZ173.4 (q), 136.1 (q), 128.4 (t),
128.1 (t), 128.0 (t), 66.0 (s), 37.5 (s), 34.1 (s), 30.6 (s), 26.3
(s), 25.6 (s), 25.4 (s), 22.8 (q), 19.5 (t), 17.8 (s); MS (FAB):
m/z 259; HRMS (FAB) found: 259.1679 m/z, calcd for
C17H23O2: MCHZ259.1698.
1
4.2.8. Spiro[2.5]octan-1-ol (2k). Colorless oil; H NMR
(400 MHz, CDCl3) dZ3.28 (1H, dd, JZ6.1, 3.0 Hz), 1.62–
1.38 (8H, m), 1.21–1.10 (2H, m), 0.47 (1H, t, JZ6.1 Hz),
0.33 (1H, dd, JZ6.1, 3.0 Hz); 13C NMR (100 MHz, CDCl3)
dZ56.5 (t), 34.7 (s), 28.8 (s), 26.3 (s), 25.9 (s), 25.0 (s), 24.3
(q), 20.2 (s).
4.2.3. Ethyl 2-spiro[2.5]octylacetate (2f). Colorless oil; IR
(neat) 2930, 1740, 1180 cmK1; 1H NMR (400 MHz, CDCl3)
dZ4.15 (2H, q, JZ7.2 Hz), 2.38 (1H, dd, JZ16.2, 7.3 Hz),
2.27 (1H, dd, JZ16.2, 7.3 Hz), 1.27 (3H, t, JZ7.2 Hz),
1.60–1.24 (10H, m), 0.91–0.81 (1H, m), 0.47 (1H, dd, JZ
8.4, 4.5 Hz), 0.01 (1H, t, JZ4.5 Hz); 13C NMR (100 MHz,
CDCl3) dZ173.8 (q), 60.2 (s), 37.6 (s), 34.2 (s), 30.7 (s),
26.4 (s), 25.6 (s), 25.1 (s), 22.8 (q), 19.5 (t), 17.8 (s), 14.2
(p); MS (FAB): m/z 197; HRMS (EI) found: 196.1467 m/z,
calcd for C12H20O2: MCZ196.1463.
4.3. General procedure for zinc-mediated cyclopropa-
nation of 1,3-diiodopropanes
Zinc powder (1.2 mmol) was added to a refluxing solution
of 1,3-diiodopropane (0.4 mmol) in EtOH (3 mL) under an
argon atmosphere. After 1–5 h at the same temperature, the
mixture was filtered through Celitew, then the solvent was
removed, and the residue was purified by preparative TLC
or column chromatography on silica gel.
4.3.1. 1,1-Dibenzylcyclopropane (7a). Colorless oil; IR
4.2.4. (2,2-Dimethylcyclopropyl)acetophenone (2g).
(neat) 3030, 2920, 1500, 1460, 1080, 1020, 760, 700 cmK1
;
Colorless oil; IR (neat) 2940, 1690, 750, 690 cmK1; H
1H NMR (400 MHz, CDCl3) dZ7.31–7.25 (4H, m), 7.24–
7.16 (6H, m), 2.56 (4H, s), 0.52 (4H, s); 13C NMR
(100 MHz, CDCl3) dZ140.1 (q), 129.5 (t), 128.0 (t), 126.0
(t), 41.5 (s), 20.8 (q), 10.7 (s); MS (FAB): m/z 222; HRMS
(EI) found: 222.1422 m/z, calcd for C17H18: MCZ
222.1409.
1
NMR (400 MHz, CDCl3) dZ7.96 (2H, m), 7.55 (1H, tt, JZ
7.4, 1.6 Hz), 7.46 (2H, m), 3.03 (1H, dd, JZ17.0, 7.0 Hz),
2.93 (1H, dd, JZ17.0, 7.2 Hz), 1.11 (3H, s), 1.06 (3H, s),
1.02–0.94 (1H, dddd, JZ8.7, 7.2, 7.0, 4.6 Hz), 0.56 (1H, dd,
JZ8.7, 4.6 Hz), 0.06 (1H, t, JZ4.6 Hz); 13C NMR